Survivin-associated adaptive response in radiation therapy

Cancer Research

Volumn 73, Issue 14, 2013, Pages 4418-4428

  Grdina, David J ^a   Murley, Jeffrey S ^a   Miller, Richard C ^a   Mauceri, Helena J ^a   Sutton, Harold G ^a   Li, Jian Jian ^c   Woloschak, Gayle E ^b   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RADIOTHERAPY; CELL SURVIVAL; COLON CARCINOMA; CONTROLLED STUDY; EMBRYO; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; SARCOMA; THERAPY EFFECT; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PREGNANCY; RADIATION DOSAGE; RADIATION TOLERANCE; RADIOTHERAPY, IMAGE-GUIDED; REPRESSOR PROTEINS; SARCOMA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84880857179     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4640     Document Type: Article

References (31)

1. Wolff S, Afzal V, Wiencke JK, Olivieri G, Michaeli A. Human lymphocytes exposed to low doses of ionizing radiations becomerefractory to high doses of radiation as well as to chemical mutagens that induce double strand breaks in DNA. Int J Radiat Biol Relat Stud Phys Chem Med 1988;53:39-47.
2. Dixon RG, Ogden K. Optimizing dose in computed tomographic procedures. Tech Vasc Interv Radiol 2010;13:172-5.
3. Bonner WM. Low-dose radiation: thresholds, bystander effects, and adaptive responses. Proc Natl Acad Sci USA 2003;100:4973-5.
4. Phan N, De Lisio M, Parise G, Boreham DR. Biological effects and adaptive response from single and repeated computed tomography scans in reticulocytes and bone marrow of C57BL/6 mice. Radiat Res 2012;177:164-75.
5. Neta R. Modulation with cytokines of radiation injury: suggested mechanisms of action. Environ Health Perspect 1997;105(Suppl. 6):1463-5.
6. Singh VK, Yadav VS. Role of cytokines and growth factors in radioprotection. Exp Mol Pathol 2005;78:156-69.
7. Murley JS, Kataoka Y, Miller RC, Li JJ, Woloschak G, Grdina DJ.SOD2- mediated effects induced by WR1065 and low dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells. Radiat Res 2011;175:57-65.
8. Murley JS, Baker KL, Miller RC, Darga TE, Weichselbaum RR, Grdina DJ. SOD2-mediated adaptive responses induced by low-dose ionizing radiation via TNF signaling and amifostine. Free Radic Biol Med 2011;51:1918-25.
9. Grdina DJ, Murley JS, Miller RC, Mauceri H, Sutton HG, Thirman MJ, et al. A manganese superoxide dismutase (SOD2)-mediated adaptive response. Radiat Res 2013;179:115-24.
10. Jones MK, Padilla OR, Webb NA, Norng M. The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol- induced injury via activation of the p34cdc2 cyclin dependent kinase. J Cell Physiol 2008;215:750-64.
11. Marivin A, Berthelet J, Plenchette S, Dubrez L. The inhibitor of apoptosis (IAPs) in adaptive response to cellular stress. Cells 2012;1:711-37.
12. Lu B, Mu Y, Cao C, Zeng F, Schneider S, Tan J, et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res 2004;64:2840-5.
13. Capalbo G, Rodel C, Stauber RH, Knauer SK, Bache M, Kappler M, et al. The role of survivin for radiation therapy: prognostic and predictive factor and therapeutic target. Strahlenther Onkol 2007;11:593-9.
14. Jin X, Gong L, Guo C, Hao JF, Wei W, Dai ZY, et al. Survivin expressions in human hepatoma HepG2 cells exposed to ionizing radiation of different LET. Radiat Environ Biophys 2008;47:399-04.
15. Rodel F, Reichert S, Sprenger T, Gaipl US, Mirsch J, Liersch T, et al. The role of survivin for radiation oncology: moving beyond apoptosis inhibition. Curr Med Chem 2011;18:191-9.
16. Rodel C, Haas J, Groth A, Grabenbauer GG, Sauer R, Rodel F. Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. Int J Radiat Oncol Biol Phys 2003;55:1341-7.
17. Huang L, Kim PM, Nickoloff JA, Morgan WF. Targeted and nontargeted effects of low-dose ionizing radiation on delayed genomic instability in human cells. Cancer Res 2007;67:1099-104.
18. Murley JS, Kataoka Y, Weydert CJ, Oberley LW, Grdina DJ. Delayed cytoprotection after enhancement of SOD2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine. Radiat Res 2002;158:101-09.
19. Murley JS, Nantajit D, Baker KL, Kataoka Y, Li JJ, Grdina DJ. Maintenance of manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by repeated administration of the free thiol form of amifostine. Radiat Res 2008;169:495-05.
20. Grdina DJ, Murley JS, Kataoka Y, Baker KL, Kunnavakkam R, Coleman MC, et al. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys 2009;73:886-96.
21. Bujold A, Craig T, Jaffray D, Dawson LA. Image-guided radiotherapy: has it influenced patient outcomes? Sem Radiat Oncol 2012;22:50-61.
22. Schwartz DL. Current progress in adaptive radiation therapy for head and neck cancer. Curr Oncol Rep 2012;14:139-47.
23. Sah NK, Munshi A, Hobbs M, Carter BZ, Andreeff M, Meyn RE. Effect of down regulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells. Int J Radiat Oncol Biol Phys 2006;66:852-9.
24. Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D, Watanabe N. Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 2000;91:1204-9.
25. Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, et al. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer 2006;107:746-56.
26. Lu YH, Luo XG, Tao X. Survivin gene RNA interference induces apoptosis in human HL60 leukemia cell lines. Cancer Biother Radiopharm 2007;22:819-25.
27. Zhang Y, Chen Z, Du C, Xu G, Luo W. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-0 cells. Path Res Pract 2009;205:823-7.
28. Aliabadi HM, Landry B, Mahdipoor P, Uludag H. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line. Mol Pharm 2011;8:1821-30.
29. Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E, et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kB/survivin and phosphoinositide 3-kinase/akt signaling pathways. Clin Cancer Res 2009;16: 77-87.
30. Kawakami H, Tomita M, Matsuda T, Ohta T, Tanaka Y, Fujii M, et al. Transcriptional activation of survivin through the NF-kB pathway by human T-cell leukemia virus type I Tax. Int J Cancer 2005;115: 967-74.
31. Li W, Wang H, Kuang C, Zhu J, Yu Y, Qin Z, et al. An essential role for the Id1/PI3K/Akt/NFkB/survivin signaling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem 2012;363:135-45.